Prostate cancer news reports: January 6, 2010

Recent reports have addressed the following issues related to prostate cancer:

  • How many biopsy cores is the right number?
  • How “open” surgeons have adapted to laparoscopic surgery
  • Hypoxia, the tumor environment, and how it affects treatment
  • Gefitinib + radiation therapy in intermediate- and high-risk prostate cancer
  • Fractures, prostate cancer, and androgen deprivation … READ MORE …

Prostate cancer news reports: Saturday, May 23, 2009

Today’s news reports focus on four items:

  • Development of aggressive prostate cancer from a single cell and tumor
  • Prostate size and risk for positive surgical margins
  • Quality of urinary function after different types of surgery
  • Gefitinib as a single agent in treatment of CRPC … READ MORE …

The prostate cancer news report: Tuesday, May 5, 2009

We are returning to “normal” today with the standard “news reports.” Today’s items deal with:

  • Evolving biomarkers and new tests and their future application
  • MRI in diagnosis, staging, and prognosis of prostate cancer
  • Intraprostatic injection of LHRH agonists and antagonists: is it viable?
  • Gefitinib in HRPC: no evident impact on quality of life … READ MORE …

The Wednesday news update: January 21, 2009

Today’s news includes information on:

  • The use of markers for prognosis following first-line treatment for localized prostate cancer
  • Results of a Phase II trial of neoadjuvant docetaxel + gefitinib prior to radical prostatectomy
  • Results of a Phase III trial of gabapentin in management of ADT-related “hot flashes”
  • MRI-directed HIFU in the treatment of localized prostate cancer … READ MORE …